{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:44:43Z","timestamp":1761007483335,"version":"build-2065373602"},"reference-count":23,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[1992,4,1]],"date-time":"1992-04-01T00:00:00Z","timestamp":702086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nut in Clin Prac"],"published-print":{"date-parts":[[1992,4]]},"abstract":"<jats:p>The use of somatostatin to manage diarrhea associated with the short gut syndrome is impractical because of its need to be given by continuous infusion and a rebound effect on stool output with cessation of therapy. Octreotide has been used more successfully to control stool and electrolyte losses in patients with shortened gastrointestinal tracts. In published series and studies, all subjects appear to decrease stool losses, but clinical benefit for longterm use is not achieved for all patients. In the patients who do respond, the need for parenteral nutrition and intravenous hydration has been decreased or eliminated. The optimal dose is unclear, but many patients respond to 50\u2010\u03bcg injections twice daily. Several investigations noted no additional beneficial effects with escalating dosages. Adverse effects include impairment of fat absorption, which may offset the therapeutic benefits of octreotide. The patients with the greatest response appear to have the least fat malabsorption. Other adverse effects noted when using octreotide for control of the short gut syndrome include pain associated with subcutaneous injection and abdominal complaints. Other potential concerns include the effect on gallstone formation in this high\u2010risk population and intestinal adaptation.<\/jats:p>","DOI":"10.1177\/011542659200700281","type":"journal-article","created":{"date-parts":[[2008,5,14]],"date-time":"2008-05-14T19:23:41Z","timestamp":1210793021000},"page":"81-85","source":"Crossref","is-referenced-by-count":9,"title":["Somatostatin and Its Analogs in the Short Bowel Syndrome"],"prefix":"10.1002","volume":"7","author":[{"given":"Gail H.","family":"Rosen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[1992,4]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"1061","article-title":"Potential gastrointestinal uses of somatostatin and its synthetic analogue octreotide","volume":"85","author":"Grosman I.","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.30.9.1165"},{"key":"e_1_2_1_4_1","first-page":"255","article-title":"Octreotide, a new somatostatin analogue","volume":"8","author":"Katz MD","year":"1989","journal-title":"Clin Pharm"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0016-5085(80)90188-2","article-title":"Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water and electrolytes","volume":"78","author":"Krejs GJ","year":"1980","journal-title":"Gastroenterology"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01300194"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/106002808802201001"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197901113000208"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(79)90643-0"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)92369-3"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198212000-00008"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.30.7.943"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800730219"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1989.tb00202.x"},{"key":"e_1_2_1_15_1","first-page":"A1434","article-title":"Does a somatostatin analogue (Octreotide) reduce the need for parenteral fluids in patients with a short bowel","volume":"29","author":"Nightingale JM","year":"1988","journal-title":"Gut"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-198705000-00026"},{"key":"e_1_2_1_17_1","first-page":"A1432","article-title":"Does somatostatin analogue (SMS 201\u2013995) reduce high output stoma effluent? A controlled trial","volume":"29","author":"Shaffer JI","year":"1988","journal-title":"Gut"},{"key":"e_1_2_1_18_1","first-page":"1025","article-title":"Use of a long acting somatostatin analogue in controlling life threatening ileostomy diarrhoea","volume":"20","author":"Williams NS","year":"1984","journal-title":"Br Med J"},{"key":"e_1_2_1_19_1","first-page":"223","article-title":"Sandostatin in the management of nonendocrine gastrointestinal and pancreatic disorders: a preliminary study","volume":"34","author":"Rosenberg L.","year":"1991","journal-title":"Can J Surg"},{"key":"e_1_2_1_20_1","first-page":"478","article-title":"Somatostatin effect on gastrointestinal losses in patients with short bowel syndrome. A.S.P.E.N","author":"Gilsdorf RB","year":"1989","journal-title":"13th Clinical Congress Abstracts"},{"key":"e_1_2_1_21_1","first-page":"A580","article-title":"Gallstone formation and occurrence of cholesterol monohydrate crystals in gallbladder bile of patients with longterm sandostatin treatment","volume":"96","author":"Buscail L.","year":"1989","journal-title":"Gastroenterology"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-6-1658"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0016-5085(83)80179-6","article-title":"Gallbladder disease in patients on long\u2010term parenteral nutrition","volume":"84","author":"Roslyn JJ","year":"1983","journal-title":"Gastroenterology"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/0148607188012003299"}],"container-title":["Nutrition in Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1177\/011542659200700281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T13:41:02Z","timestamp":1760967662000},"score":1,"resource":{"primary":{"URL":"https:\/\/aspenjournals.onlinelibrary.wiley.com\/doi\/10.1177\/011542659200700281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,4]]}},"alternative-id":["10.1177\/011542659200700281"],"URL":"https:\/\/doi.org\/10.1177\/011542659200700281","archive":["Portico"],"relation":{},"ISSN":["0884-5336","1941-2452"],"issn-type":[{"type":"print","value":"0884-5336"},{"type":"electronic","value":"1941-2452"}],"subject":[],"published":{"date-parts":[[1992,4]]}}}